Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 210.42%3.24M | 111.06%732K | 46.82%762K | -34.81%236K | -45.95%1.51M | 82.32%-2.94M | 10.28%-6.62M | 105.90%519K | 50.83%362K | 509.50%2.8M |
| Net profit before non-cash adjustment | 41.57%-6.23M | 84.90%-1.17M | -124.76%-2.36M | 56.77%-492K | -205.11%-2.21M | 59.50%-10.67M | 60.21%-7.75M | 71.64%-1.05M | 33.02%-1.14M | 49.79%-724K |
| Total adjustment of non-cash items | -45.37%6.2M | -79.14%1.77M | --1.52M | -7.12%1.42M | 11.31%1.49M | -48.46%11.35M | -47.86%8.49M | --0 | 10.23%1.53M | 0.60%1.34M |
| -Depreciation and amortization | 14.46%6.07M | -30.53%1.77M | --1.46M | -1.99%1.43M | 9.13%1.42M | 61.18%5.31M | 923.12%2.55M | --0 | 201.66%1.45M | 204.67%1.3M |
| -Reversal of impairment losses recognized in profit and loss | --0 | --0 | --0 | --0 | --0 | 87.03%6.55M | 646.41%6.55M | --0 | --0 | --0 |
| -Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Net exchange gains and losses | -184.09%-37K | --0 | ---3K | -1,200.00%-52K | 228.57%18K | 446.46%44K | --62K | --0 | ---4K | ---14K |
| -Remuneration paid in stock | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| -Other non-cash items | 130.28%165K | --0 | --72K | -40.00%48K | 0.00%45K | -776.72%-545K | -27,091.56%-670K | --0 | 150.00%80K | 80.00%45K |
| Changes in working capital | 190.39%3.28M | 101.81%133K | 1.85%1.6M | -2,210.00%-693K | 2.15%2.24M | 70.57%-3.62M | -76.48%-7.35M | 119.30%1.57M | -105.44%-30K | 484.89%2.19M |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | 53.55%-4.79M | ---- | ---- | ---- | ---- |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | -369.91%-625.57K | ---- | ---- | ---- | ---- |
| -Change in payables | ---- | ---- | ---- | ---- | ---- | 137.17%694.62K | ---- | ---- | ---- | ---- |
| -Changes in other current assets | 66.55%-1.81M | 111.27%699K | -82.68%-3.83M | -98.26%26K | -6.84%1.29M | ---5.41M | -132.27%-6.2M | -379.84%-2.1M | -60.52%1.5M | 174.15%1.39M |
| -Changes in other current liabilities | 183.98%5.09M | 50.70%-566K | 48.08%5.43M | 52.95%-719K | 17.71%944K | --1.79M | ---1.15M | 141.29%3.67M | 52.88%-1.53M | -38.45%802K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 0 | 0 | 0 | 46K | -46K | 0 | 125K | -125K | 0 | 0 |
| Interest received (cash flow from operating activities) | 0.00%1K | 0 | 0 | 0 | 1K | -89.41%1K | -89.41%1K | 0 | 0 | 0 |
| Tax refund paid | 50.00%-150K | 0 | 0 | 0.00%-75K | 0.00%-75K | 0.75%-300K | 50.09%-75K | 66.37%-75K | -150.68%-75K | 2.60%-75K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 195.61%3.1M | 111.14%732K | 138.87%762K | -27.87%207K | -48.86%1.39M | 80.86%-3.24M | 12.35%-6.57M | 103.52%319K | -30.51%287K | 458.21%2.73M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 23.47%-3.13M | 77.47%-801K | -224.52%-1.1M | 53.82%-151K | 0.82%-1.08M | 81.39%-4.09M | -167.12%-3.56M | 104.84%881K | 86.12%-327K | 83.83%-1.09M |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---40K | ---- | ---- | ---- | ---- |
| Repayment of advance payments to other parties and cash income from loans | --184K | --144K | --0 | --10K | --30K | ---- | ---- | ---- | ---- | ---- |
| Investing cash flow | 28.66%-2.95M | 81.72%-657K | -224.52%-1.1M | 56.88%-141K | 3.57%-1.05M | 81.21%-4.13M | -167.87%-3.6M | 104.84%881K | 86.12%-327K | 83.83%-1.09M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 213.33%68K | --0 | -2.99%-69K | 98.49%-11K | 121.51%148K | -102.43%-60K | -42.50%1.42M | ---67K | ---727K | ---688K |
| Net common stock issuance | -93.03%528K | --0 | -93.95%277K | ---- | ---- | -79.66%7.58M | 76.51%3M | -82.30%4.58M | --0 | --0 |
| Increase or decrease of lease financing | -24.21%-549K | --0 | -363.77%-320K | -85.48%-115K | 19.72%-114K | 57.79%-442K | 75.41%-169K | ---69K | 67.88%-62K | 14.97%-142K |
| Interest paid (cash flow from financing activities) | 31.69%-166K | --0 | ---72K | 40.00%-48K | -2.22%-46K | -93.21%-243K | -175.89%-118K | --0 | -150.00%-80K | -80.00%-45K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | 100.33%3K | ---- | ---- | ---- | ---- |
| Financing cash flow | -101.74%-119K | --0 | -104.14%-184K | 108.86%77K | 98.63%-12K | -81.85%6.84M | 63.05%4.14M | -82.81%4.44M | -286.22%-869K | -109.20%-875K |
| Net cash flow | ||||||||||
| Beginning cash position | -150.65%-194K | -103.48%-205K | 24.40%311K | -89.96%116K | -150.65%-194K | -76.39%383K | 19,543.33%5.89M | -82.69%250K | -68.02%1.16M | -76.39%383K |
| Current changes in cash | 105.07%27K | 101.24%75K | -109.20%-519K | 115.73%143K | -56.73%328K | 57.40%-533K | -1,868.34%-6.03M | 499.08%5.64M | 58.07%-909K | -61.91%758K |
| Effect of exchange rate changes | 184.09%37K | --0 | --3K | 1,200.00%52K | -228.57%-18K | -446.46%-44K | ---62K | --0 | --4K | --14K |
| End cash Position | 32.99%-130K | 32.99%-130K | -103.48%-205K | 24.40%311K | -89.96%116K | -150.61%-194K | -150.61%-194K | 19,543.33%5.89M | -82.69%250K | -68.02%1.16M |
| Free cash flow | 99.48%-38K | 99.32%-69K | -127.92%-335K | 240.00%56K | -81.02%310K | 81.38%-7.33M | -283.07%-10.12M | 104.40%1.2M | 97.94%-40K | 121.72%1.63M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.